2287. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been undertaken regarding maintenance and technical agency staffing expenditure in 2025. [43574/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Health Services.
407 questions match, newest first.
2288. Deputy Ken O'Flynn asked the Minister for Health whether the increase was anticipated in workforce plans and budget forecasts; and if not, when the variance was first identified. [43575/26]
2423. Deputy Ken O'Flynn asked the Minister for Health the percentage of children treated within the target waiting time applicable to their assigned Clinical Priority Category in Children’s Health Ireland in each year since 2020. [44065/26]
2424. Deputy Ken O'Flynn asked the Minister for Health whether Children’s Health Ireland reports performance against Clinical Priority Category waiting-time targets to the HSE or their Department; and if so, the frequency and format of such reporting. [44066/26]
2425. Deputy Ken O'Flynn asked the Minister for Health whether any national written criteria, guidance documents, policy directives, clinical governance documents or decision-support frameworks currently exist which distinguish between procedures regarded as medically necessary, elective, quality-of-life, cosmetic or discretionary for public funding purposes; and if so, if she will provide details of each such docume…
2426. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has conducted any review since 2020 of variation in decision-making between hospitals, specialties or Health Regions regarding eligibility for publicly funded procedures; and if any such review has been undertaken, if she will provide the findings and recommendations. [44068/26]
2427. Deputy Ken O'Flynn asked the Minister for Health whether any national audit has been undertaken since 2020 examining consistency in decisions regarding access to publicly funded procedures across different clinical specialties; and if not, whether she considers the absence of a national classification framework creates a risk of inconsistent decision-making. [44069/26]
2428. Deputy Ken O'Flynn asked the Minister for Health the governance mechanism that exists to ensure that a procedure approved for public funding in one hospital or specialty is assessed against equivalent criteria in another hospital or specialty. [44070/26]
2433. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1029 of 19 May 2026, the estimated additional annual PCRS expenditure attributable solely to the 2022 steri-neb salamol price uplift, excluding any increase arising from changes in prescribing volume or item numbers; and if they will provide the methodology used in calculating that estimate. [44075/26]
2434. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken or commissioned any literature review, evidence assessment or toxicological review since 2020 regarding potential neurological, developmental or cognitive effects associated with long-term exposure to manganese concentrations between 50 µg/l and 80 µg/l in drinking water; and if so, if details of each review will be provided. [44082…
2435. Deputy Ken O'Flynn asked the Minister for Health whether the HSE possesses any documented risk assessment, scientific briefing, technical paper or expert advice supporting its position that there is currently no scientific evidence of adverse health effects at manganese concentrations up to 80 µg/l; and if copies of such documents will be provided. [44083/26]
2436. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has reviewed any scientific literature published since July 2024 concerning manganese exposure through drinking water; and whether any such evidence has prompted consideration of revising the July 2024 FAQ guidance. [44084/26]
2437. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records, at national level, the number of patients awaiting orthopaedic outpatient assessment who have not yet been placed on an inpatient or day-case surgical waiting list; and if so, the current number, broken down by hospital group and orthopaedic subspecialty. [44094/26]
2438. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can quantify the average period between referral to orthopaedic outpatient services and subsequent placement on an inpatient or day-case waiting list for knee replacement surgery. [44096/26]
2439. Deputy Ken O'Flynn asked the Minister for Health whether a national standard exists requiring hospitals to inform patients in writing whether they are on an outpatient waiting list or an inpatient/day-case surgical waiting list; and if so, to provide a copy of that standard. [44097/26]
667. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme appears on any HSE or Departmental risk register, internal audit plan or audit universe; and if so, under what risk category. [41236/26]
675. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains structured follow-up data on clinical outcomes, complications, revision procedures, readmissions or adverse events arising after treatment abroad scheme-funded procedures. [41244/26]
678. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central data set of treatment abroad scheme approvals including procedure type, jurisdiction, provider, cost, clinical indication, approval date and outcome data. [41247/26]
257. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the treatment abroad scheme in each year since 2020; the number of approved patients in each year; and the average approved expenditure per patient annually. [40614/26]
258. Deputy Ken O'Flynn asked the Minister for Health whether expenditure and activity data reviewed during quarterly treatment abroad scheme oversight meetings with the Department of Health is recorded in a standardised reporting format; and if she will provide copies of the reporting templates used. [40615/26]
259. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records activity data by clinical speciality, treatment category, age cohort or referral pathway; and if she will provide a breakdown of the categories currently recorded. [40616/26]
260. Deputy Ken O'Flynn asked the Minister for Health the dates on which the treatment abroad scheme was audited by the HSE Internal Audit function or the Comptroller and Auditor General since 2020; the scope of each audit; and whether any recommendations or governance concerns were identified. [40617/26]
261. Deputy Ken O'Flynn asked the Minister for Health whether any internal reports, dashboards, expenditure summaries or performance-monitoring documents relating to the treatment abroad scheme are routinely furnished to the Department of Health; and if she will provide details of the documents concerned. [40618/26]
262. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains separate expenditure or activity reporting for referrals involving minors. [40619/26]
263. Deputy Ken O'Flynn asked the Minister for Health the number of treatment abroad scheme applications submitted, approved, refused and withdrawn in each HSE health region in each year since 2020. [40620/26]